EUVIMEDEUVIMED entdecken
Crossref

A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria

Suzia Aktar Suchi, Kyung Bin Nam, Young Kyun Kim, Hasan Tarek, Jin Cheol Yoo

Bioprocess and Biosystems Engineering · 2023-06 · 46 (6) · 813-828

DOI: 10.1007/s00449-023-02864-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioprocess and Biosystems Engineering, online erschienen am 30.03.2023. Verfasst von Suzia Aktar Suchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea. Hauptthemen laut MEDLINE: Bacillus, Anti-Infective Agents. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: jin cheol yoo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nowadays, the abuse of antibiotics has led to the rise of multi-drug-resistant bacteria. Antimicrobial peptides (AMPs), with broad-spectrum antimicrobial activity have attracted considerable attention as possible alternatives to traditional antibiotics. In this work, we aimed to evaluate the antimicrobial and anti-biofilm activity of an antimicrobial peptide designed as YS12 derived from Bacillus velezensis CBSYS12. The strain CBSYS12 was isolated from Korean food kimchi and purified followed by ultrafiltration and sequential chromatographic methodology. Hereafter, Tricine SDS-PAGE revealed a single protein band of around 3.3 kDa that was further confirmed in situ inhibitory activity of the gel. A similar molecular weight (~ 3348.4 Da) protein also appeared in MALDI-TOF confirming the purity and homogeneity of peptide YS12. Intriguingly, YS12 revealed a strong antimicrobial activity with a minimum inhibitory concentration (MIC) value ranging from 6 to 12 μg/ml for both Gram-positive and Gram-negative bacteria, such as E. coli, P. aeruginosa, MRSA 4-5, VRE 82, and M. smegmatis. We also determined the mode of action of the peptide against pathogenic microorganisms using different fluorescent dyes. In addition, the anti-biofilm assay demonstrated that peptide YS12 was able to inhibit biofilm formation around 80% for both bacterial strains E. coli and P. aeruginosa at 80 µg/ml. Notably, YS12 exhibited a greater biofilm eradication activity than commercial antibiotics. In summary, our study proposed that peptide YS12 may be used as a promising therapeutic agent to overcome drug and biofilm-related infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacillusAnti-Infective AgentsAnti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic PeptidesEscherichia coliGram-Negative BacteriaBacteriaMicrobial Sensitivity TestsBiofilms

Stichwörter der Autor:innen

Anti-biofilm activityAntimicrobial peptides (AMPs)Mechanism of actionMultidrug-resistant bacteria

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic PeptidesAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea. jcyu@chosun.ac.kr.

Förderung

  • jin cheol yoo

Zitieren

APA

Suchi, S. A., Nam, K. B., Kim, Y. K., Tarek, H., & Yoo, J. C. (2023). A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria. Bioprocess and Biosystems Engineering, 46(6), 813-828. https://doi.org/10.1007/s00449-023-02864-7

Vancouver

Suchi SA, Nam KB, Kim YK, Tarek H, Yoo JC. A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria. Bioprocess and Biosystems Engineering. 2023;46(6):813-828. doi:10.1007/s00449-023-02864-7

BibTeX
@article{Suchi2023,
  author = {Suchi, Suzia Aktar and Nam, Kyung Bin and Kim, Young Kyun and Tarek, Hasan and Yoo, Jin Cheol},
  title = {A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria},
  journal = {Bioprocess and Biosystems Engineering},
  year = {2023},
  volume = {46},
  number = {6},
  pages = {813--828},
  doi = {10.1007/s00449-023-02864-7}
}
Kostenlos starten →